Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 1Polycystic Ovary Syndrome 1Pituitary Neoplasms 1

Interventions

Metformin 52Inositol 21Clomiphene 17Letrozole 16Exercise 14High-Intensity Interval Training 10Folic Acid 10Caloric Restriction 10Progesterone 8Ethinyl Estradiol 8Estradiol 7Diet 6drospirenone 5drospirenone and ethinyl estradiol combination 4Tablets 4In Vitro Oocyte Maturation Techniques 4Estrogens 4Diet, Mediterranean 4Cyproterone Acetate 4Control Groups 4Berberine 4Acupuncture Therapy 4Vitamin D 3Triptorelin Pamoate 3Thioctic Acid 3Spironolactone 3Resistance Training 3Pioglitazone 3Medroxyprogesterone Acetate 3Flutamide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Polycystic Ovary Syndrome × Rosiglitazone × Clear all
NCT01019356 2022-01-20

Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome

Université de Sherbrooke

Phase NA Completed
52 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡